Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
USG-Guided ACB and IPACK Block for Post-TKA Analgesia
NCT05956275Phase 4Completed
- Sponsor
- Siirt Training and Research Hospital
- Start
- Dec 2020
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Siirt Training and Research Hospital. Primary endpoints: Total Tramadol Consumption at 24 hours and Use of Morphine as Rescue Analgesia at 24 hours. Started Dec 2020; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05956275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05956275.